Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Ravaud, R.J. Motzer, H.S. Pandha, M. Staehler, D. George, A.J. Pantuck, A. Patel, Y-H. Chang, B. Escudier, F. Donskov, A. Magheli, G. Carteni, B. Laguerre, P. Tomczak, J. Breza, P. Gerletti, X. Lin, M. Lechuga, J-F. Martini, J-J. Patard | ||||||||||||
Title | Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC) | ||||||||||||
|
|||||||||||||
URL | http://www.esmo.org/Conferences/ESMO-2016-Congress/Press-Media/Longer-Disease-free-Survival-in-Phase-III-Trial-of-Sunitinib-as-Adjuvant-Treatment-for-Kidney-Cancer | ||||||||||||
Abstract Text | ESMO 2016 Congress in Copenhagen, Abstract LBA11_PR |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|